Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
Kamal S. Saini(Institut Jules Bordet), Martine Piccart(Institut Jules Bordet)
Cited by 378
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
|JNCI Journal of the National Cancer Institute|2006|1.2k
Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies
|European Journal of Cancer|2020|344